Life sciences news
-
RheaVita closes EUR 2.5 million Series A Financing co-led by Novalis Biotech Acceleration and PMV
Wednesday June 2nd 2021
Read more
-
Investment in Flow Cytometry unlocks the secrets of single cells
Thursday May 20th 2021
Read more
-
Droia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski
Tuesday May 11th 2021
Read more
-
Biocartis receives EUR 1.4m grant to support development of new Idylla™ technology to unlock potential in molecular surveillance
Tuesday May 11th 2021
Read more
-
Biocartis announces US FDA 510(k) submission of its Idylla™ MSI Test
Tuesday April 20th 2021
Read more
-
The European Circular Bioeconomy Fund (ECBF) expands Aphea.Bio Series B funding round to EUR 18 million
Wednesday April 14th 2021
Read more
-
Confo Therapeutics awarded EUR 1M VLAIO grant for pre-clinical development of CFTX-1554
Wednesday March 31st 2021
Read more
-
Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases
Tuesday March 23rd 2021
Read more
-
Become a flanders.bio member
Your news here?
-
AgomAb Therapeutics kondigt $74 miljoen series-B financiering aan
Wednesday March 10th 2021
Read more
-
Rejuvenate Biomed secures EUR 3.2 million series A round to advance development of healthy aging products
Tuesday March 2nd 2021
Read more
-
Newton Biocapital invests in Flemish start-up DeuterOncology
Wednesday February 24th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
